Cascade liposomal delivery for glioblastoma through multi-stage biological checkpoints.
Although receptor-targeted liposomes provide promising opportunities for glioblastoma therapy, their clinical translation remains limited by sequential biological barriers encountered after systemic administration. Here, we establish a multi-stage checkpoint framework linking carrier properties with stage-specific tran...